IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Summary

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)

Timeline

Start

2021-06-17

Primary completion

2027-03-31

Completion

2027-03-31

Drugs

Indications